A review of the literature                                              

Lindsay Brooks, PhD, Bausch & Lomb
Ciprés M.C., MD. Chief of the Department of Ophthalmology,
University Hospital San Rafael, Barcelona, Spain.

1.8MMBiaxialMICS.PDF

The Akreos IOLs                                                             Clinically Proven to Provide Quality of Vision                          

By Anders Behndig, MD, PhD, Roberto Bellucci, MD,             
Joel Pynson, MD (B&L), & Lindsay Brooks, PhD (B&L)

AkreosIOLsClinicals.PDF

Air Force Ophthalmologists Find Color-Vision Deficits With a “Blue-Blocker” IOL Filter                                                   Study Recommends Continued Prohibition on Usage of This Lens by Aircrew

Summary April 2007

Blue blocking white paper.pdf

-----------------------------------------------------------

A Reality Check on IOL Opacification
Recent Research Puts This Complication into Perspective Alongside Other Causes of Explants

George Green, Ph.D.
Director, Research & Development Bausch & Lomb

IOL Opacification.pdf

Making the Move to Microincisions
New IOLs, StellarisTM and MICS-Ready Surgical Instruments Will Work Together to Facilitate the Switch to SmallerIncision Phaco Surgeries

Keith Edwards, BSc FCOptom DipCLP FAAO
Director, Global Scientific & Clinical Affairs
Cataract & Vitreoretinal Technologies
James Perkins, Sr. Principal Engineer, BSME

Moving to MICS.pdf

Violet-Blocking: Balancing Retinal Function and Protection
Preventing the riskiest part of the visible spectrum from reaching the retina without compromising vision or disrupting circadian rhythms

Louis D. "Skip" Nichamin M.D. Medical Director Laurel Eye Clinic Brookville, Pennsylvania
David R. Chow M.D. F.R.C.S.C Assistant Professor University of Toronto

Violet blocking - Nichamin.pdf